ClinicalTrials.gg
Not yet recruitingNCT07208994PATH2KTUpdated Oct 6, 2025

Pathways to Equitable Access to Kidney Transplantation in Spain: A Transformative Mixed-methods Study Protocol

An observational study in Chronic Kidney Disease and Kidney Transplant, sponsored by Hospital del Mar. Not yet recruiting at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-10-06.

Sponsored by Hospital del Mar · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
3,000
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 188 studies in Renal Insufficiency, Chronic with a site in Spain — 38 open to participants now, 55 under way, 23 of them phase 3. Renal Insufficiency, Chronic · Spain.

Planned enrollment
8th of 34
3,000 · median 397
Started
2026
with 14 others
Observational
34 of 188
10 open now
Primary completion
2026-12
later than 17 of 54 live
Registered
165th of 188
by date

Among the 188 studies in Renal Insufficiency, Chronic with a site in Spain, this one is the 8th largest by planned enrollment of the 34 observational ones that give a count, is one of 15 that started in 2026, is one of 34 observational ones, reaches primary completion later than 17 of the 54 other live ones, and was the 165th registered.

Renal Insufficiency, Chronic

3,098 studies on the registry are indexed under Renal Insufficiency, Chronic; 700 are open to participants now.

Browse Renal Insufficiency, Chronic studies →

Open to participants now

38 of the 188 studies in Renal Insufficiency, Chronic with a site in Spain are open now. Recruiting first, the newest first:

33 more — sign in →

All 38 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 434 Renal Insufficiency, Chronic studies recruiting now, 245 (56%) set no upper age limit and 110 (25%) stop at 75 or younger; 43 take children under 18; 80 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 188 studies in Renal Insufficiency, Chronic with a site in Spain, or all of them as a file.
02

Study summary

Introduction. Chronic kidney disease (CKD) affects 10%-15% of the global population and is projected to become the fifth leading cause of years of life lost by 2040. Despite the benefits of kidney transplantation (KT), access remains inequitable. In Spain, which leads the world in KT rates per million population, disparities may persist due to structural, territorial, and professional barriers. This study aims to explore the mechanisms underlying treatment deprivation and inequity in KT access using a mixed-methods approach.

Methods and analysis. A transformative mixed-methods design will be implemented in four phases: (1) systematic reviews on instruments assessing treatment deprivation and inequalities in CKD and KT; (2) a multicenter quantitative study and qualitative interviews with professionals and patients; (3) a pre-experimental evaluation of a training program on KT; and (4) triangulation and translation of findings to inform national policy. The protocol adheres to GRAMMS and PRISMA guidelines.

Ethics and dissemination. Approved by the Hospital del Mar Research Institute Ethics Committee (ID: XX), the study complies with EU data protection laws. Informed consent will be obtained. Findings will be disseminated via peer-reviewed publications, conferences, social media, and patient forums to support equity-focused strategies in KT.

Read the detailed description

METHODS AND ANALYSIS >> Study design The design of this research protocol follows the premises of the mixed-methods approach under the transformative paradigm 26,27. This means that various phases of data collection -both quantitative and qualitative- will be conducted, analyzed separately, and then integrated through methodological triangulation to corroborate and enrich the findings 28. The research will be centered on social justice, amplifying the voices of communities facing health inequalities or treatment deprivation. Using the transformative mixed-methods approach, different power structures that may be involved in the results will be analyzed and linked to actions that promote equity, ultimately providing a report with recommendations for action based on the results obtained 26,27. The achievement of results under this methodology and paradigm will be accomplished through various research phases, explained in detail below.

This protocol follows the Good Reporting of A Mixed Methods Study (GRAMMS) guidelines, recognized for ensuring high-quality evidence-based methodology 29.

  • Patient and public involvement This protocol has been reviewed and endorsed by the CKD community in Spain, including the National Federation of Associations for the Fight Against Kidney Diseases (ALCER) and the ADER Foundation (Kidney Patients Association of Catalonia). These organizations will actively support the dissemination of the study in different regions and will facilitate recruitment of participants during the data collection phase. Moreover, patient representatives will be involved in the interpretation of findings, ensuring that the analysis incorporates lived experiences and enhances the relevance and clarity of results.
  • Study setting and context The data collection components of this research protocol will be conducted in Spain, a high-interest setting for the care of people with CKD. Spain's healthcare system is public and universal, primarily funded through taxes, ensuring healthcare access for the entire population, including individuals requiring KT 30. The country is internationally recognized for its high rates of organ donation and transplantation, supported by the Spanish National Transplant Organization (Organización Nacional de Trasplantes, ONT), which emphasizes coordination, regulation, and public engagement 31. Spain's healthcare system is also highly decentralized, with responsibilities for healthcare planning, service delivery, and resource allocation delegated to the 17 autonomous regions. This structure includes regional transplant coordination offices that work in alignment with the ONT to implement national policies at the local level, but may also reflect regional specificities and priorities. Despite this strong institutional framework, inequities in KT access might arise from factors such as socioeconomic status, geographic area and interregional differences linked to the decentralized organization of the healthcare system. By focusing solely on the Spanish context, while allowing for international discussion across the proposed phases, this study seeks to generate detailed insights and propose actionable recommendations grounded in the realities of Spain's healthcare infrastructure and sociopolitical landscape.
  • Data collection and analysis Data collection and analysis will be carried out using a mixed approach, combining both quantitative and qualitative methods. This will result in four distinct research phases, tailored to the specific objectives of this research protocol.

    • Phase 1. Literature review The first phase of this study aims to address objectives 1 and 2, which focus on synthesizing and critically appraising the existing literature on instruments and variables used to evaluate inequities among individuals with CKD, as well as on examining how unequal access to KT is described and explained. To achieve this, two systematic reviews will be conducted.

Both reviews will be carried out following the methodological recommendations of the Joanna Briggs Institute (JBI) and will be reported according to the PRISMA 2020 guidelines 32,33. The protocols for the reviews will be registered in PROSPERO®. Searches will be conducted in the major electronic databases, using controlled vocabulary (MeSH) and will include peer-reviewed studies published between 2015 and 2025 in English, Spanish, French, or Portuguese. Eligibility criteria will be based on the PICOT framework, and include quantitative, qualitative, and mixed-methods research, as well as systematic and scoping reviews. Study selection, data extraction, and critical appraisal will be carried out independently by two or more reviewers, with discrepancies resolved by consensus or consultation with a third reviewer. Covidence® software will be used to manage the workflow.

Given the expected methodological heterogeneity, results will be synthesized narratively and organized thematically, according to the domains assessed, levels of analysis, validation approaches, and applicability of the instruments in both clinical and research contexts. These findings will provide a foundational knowledge base for the subsequent phases of the study.

> Phase 2. Inequities analysis This phase addresses objectives 3 and 4 by examining inequities in access to KT among individuals with CKD.

For the quantitative component (objective 3), a descriptive study will be conducted across Spain using a snowball sampling strategy through healthcare networks and patient organizations to ensure representativeness and inclusivity. Recruitment will continue until data saturation is reached, with a minimum of 500 participants to guarantee diversity across sociodemographic groups. Data will be collected through the questionnaires developed in Phase 1 (Appendix 1), complemented with sociodemographic and clinical variables to provide a comprehensive understanding of participants' health status and backgrounds. A multi-channel strategy will be applied to facilitate recruitment, involving healthcare professionals at nephrology and transplant centers, national and regional patient associations such as ALCER and ADER, and an online standardized interest form disseminated through institutional and collaborative networks, including ONT, SEDEN, and SEN. All participants will receive an information sheet and will be able to contact the research team directly to confirm their participation. No clinical information will be accessed without explicit consent, and contact details will only be shared if the participant initiates communication. This decentralized approach ensures voluntary participation and strict compliance with ethical standards in research involving potentially vulnerable populations. Statistical analysis will be carried out using SPSS® software. Descriptive statistics, including means, medians, standard deviations, and frequencies, will be used to summarize the sample characteristics, while inferential analyses such as t-tests, Wilcoxon tests, chi-square tests, and regression models will be applied depending on the type and distribution of the data. Assumptions for parametric tests will be verified, with non-parametric alternatives used when appropriate. Missing data will be managed through multiple imputation or complete-case analysis, depending on the extent and pattern of missingness, in order to ensure the robustness and validity of the findings.

For the qualitative component (objective 4), a descriptive study with a phenomenological orientation will be conducted to explore and understand in depth the experiences, perceptions, and meanings attributed to treatment deprivation by both healthcare professionals and individuals living with CKD. This approach will enable the identification of common patterns and differences between perspectives, providing a comprehensive view of the phenomenon from both sides of the healthcare relationship. Data will be collected through semi-structured, in-depth interviews guided by open-ended, non-directive questions designed to foster a fluid dialogue between interviewer and participant (Appendix 2). Two main groups of participants will be included: healthcare professionals involved in CKD care and KT, and patients with direct experience in the transplant process, including evaluation, waiting list, or transplantation. Healthcare professionals must have at least two years of experience in nephrology, transplant coordination, or related fields. Participants will be selected using purposive sampling with maximum variation to ensure diversity in roles, stages of CKD, and geographic regions. Interviews will be conducted by trained researchers or research assistants experienced in qualitative interviewing and working with vulnerable populations. Sessions will take place either in private spaces at participating healthcare centers (e.g., hospitals, transplant units, nursing schools) or through secure video calls, according to participants' preferences and availability, ensuring accessibility. Each interview is expected to last between 45 and 60 minutes, will be audio-recorded with prior consent, and subsequently transcribed verbatim for analysis. Follow-up interviews will be scheduled if necessary. Recruitment will continue until theoretical saturation is reached, defined as the point where no new themes or categories emerge from additional data 34. Data will be analyzed inductively using a thematic approach and content analysis to identify and categorize recurring patterns, with successive steps of coding, grouping into categories, and synthesizing into central themes. To ensure credibility and rigor, strategies such as investigator triangulation, participant validation, and reflective journaling of analytical decisions will be applied 35. All data will be anonymized using unique codes, stored securely, and handled in compliance with ethical standards. Atlas.ti software will be used to support the analytic process.

Upon completing this second research phase, we will have detailed data on inequities in access to KT in the Spanish context, together with the meanings attributed to this phenomenon by both the professional community and patients, providing comprehensive insights to inform the subsequent phases of the study.

> Phase 3. Impact of training In this third phase, objective 5 will be addressed by evaluating the impact of a training course in Spain on living donor KT for healthcare professionals. This particular course has been selected due to its established relevance within the Spanish context and potential impact upon access to KT: it has already completed three successful editions and has gained national recognition as one of the most important and well-regarded training programs on KT in Spain. Notably, the course is aimed at professionals working in non-transplant centers, particularly dialysis units and advanced CKD clinics, which positions it to directly influence early referral pathways and improve access to KT. Its consolidated presence and perceived influence on clinical practice make it a strategic candidate for evaluation.

A preexperimental quantitative study will be conducted with a pretest-posttest design. The study population will consist of healthcare professionals participating in the training, selected through convenience sampling. Data collection will be carried out through a structured questionnaire that will measure participants' knowledge, attitudes, and practices before, after, and one year after the course (Appendix 3). The questionnaire will include multiple-choice questions to assess knowledge, Likert scales to analyze attitudes, and questions about behaviors and clinical decision-making regarding living donor KT. The instrument's validity and reliability will be verified through prior piloting and consensus among the research team. Data analysis will involve descriptive statistics to characterize the sample and compare pre- and post-intervention results. Statistical tests such as the paired t-test or the Wilcoxon test, depending on the data distribution, will be applied to determine whether significant differences exist after training. Additionally, effect size measures, such as Cohen's d for continuous variables and Cramer's V for categorical variables, will be calculated to quantify the impact of the course on the evaluated variables.

The results obtained will help identify the effectiveness of the course in improving healthcare professionals' knowledge and perceptions about living donor KT, which can serve as the basis for future training strategies and for optimizing equitable access to KT within Spain.

> Phase 4. Integration of findings and contribution to the ATRAE national plan In the fourth and final phase of the project, the results obtained in the previous stages will be triangulated and synthesized to generate comprehensive, evidence-based knowledge (objective 6). This phase is conceived as an integrative component that will enable the transfer of research findings into actionable recommendations, directly contributing to the development of the national strategy for improving access to KT in Spain. The synthesis will support the creation of a consensus document within the ATRAE project: Optimizing Access to Kidney Transplantation in Spain. ATRAE is a national initiative led by the ONT, the Transplant Commission of the Interterritorial Council of the Spanish National Health System (CIT-SNS), and the Spanish Society of Nephrology (SEN), in collaboration with the Spanish Association of Urology (AEU), the Spanish Society of Nephrology Nursing (SEDEN), the Spanish Society of Immunology (SEI), and the Spanish Transplant Society (SET), and with the participation of the National Federation of Associations for the Fight Against Kidney Diseases (ALCER).

The research team will analyze and interpret the findings from both the quantitative and qualitative components, applying a triangulation process to enhance the validity and depth of interpretation. The results will be structured around key thematic areas such as regional disparities, evaluation and KT access processes, healthcare professional training, and the influence of social and structural determinants. Based on this synthesis, technical briefs will be prepared to highlight the most relevant insights, propose improvement strategies, and identify aspects that require further attention. These materials will be shared with the ATRAE working groups and coordination bodies, with the goal of supporting evidence-based decision-making and facilitating the integration of research findings into ongoing national planning processes.

Through this knowledge translation effort, the study positions itself as a relevant and timely contributor to the development of public policies, ensuring that its findings are not only scientifically rigorous but also transferable, actionable, and aligned with the institutional framework responsible for promoting equity in access to KT in Spain.

03

Conditions studied

  • Chronic Kidney Disease
  • Kidney Transplant
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

A transformative mixed-methods design will be implemented in four phases: (1) systematic reviews on instruments assessing treatment deprivation and inequalities in CKD and KT; (2) a multicenter quantitative study and qualitative interviews with professionals and patients; (3) a pre-experimental evaluation of a training program on KT; and (4) triangulation and translation of findings to inform national policy.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • People with CKD

Exclusion criteria

Exclusion Criteria:

  • Pediatrics
05

Study design

Observational model
Other
Time perspective
Other
Enrollment
3,000 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Interventions

  • OtherDescription

    No intervention

06

What researchers measure

Primary outcomes

  1. Inequities in access to kidney transplantation among individuals with chronic kidney disease

    Quantitative assessment of inequities in access to kidney transplantation using validated questionnaires developed in Phase 1, complemented by sociodemographic and clinical variables. The outcome will measure disparities according to age, sex, socioeconomic status, region, and clinical condition.

    Time frame: Baseline (at study inclusion)

Secondary outcomes

  1. Patient experiences related to access to kidney transplantation

    Analysis of experiences collected through structured questionnaires to evaluate patients' perceptions of their health status, quality of life, and barriers or facilitators in the transplant process.

    Time frame: Baseline (at study inclusion)

  2. Professional perspectives on inequities in access to kidney transplantation

    Qualitative assessment through semi-structured interviews with nephrologists, nurses, healthcare managers, and patient advocates to explore their perceptions of systemic inequities and barriers in the transplant pathway.

    Time frame: Within the first 12 months of the study

Other outcomes

  1. Thematic categories of inequities in kidney transplantation access

    Inductive thematic analysis of qualitative data to identify key categories and central themes related to inequities in transplantation access, triangulated with quantitative findings.

    Time frame: At study completion (24 months)

07

Study locations

1 site
  • Escola Superior d'Infermeria Hospital del Mar
    Barcelona, 08020, Spain
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — The following individual participant data (IPD) will be shared: de-identified sociodemographic variables (e.g., age, sex, region), clinical variables related to kidney disease stage and treatment modality, and responses to patient-reported outcome and experience measures (PROMs and PREMs) collected through standardized questionnaires. Data will be shared in aggregated and anonymized format to ensure confidentiality and will be used exclusively for research purposes in accordance with ethical approvals and participant consent.

Supporting information: Study protocol, Informed consent form

Time frame: Individual participant data (IPD) will become available after completion of the study and publication of the main results. Data will remain accessible for a period of 5 years following publication.

Access criteria: De-identified individual participant data will be made available to qualified researchers upon reasonable request. Access will require submission of a research proposal that aligns with the study objectives, approval by the principal investigator, and a signed data access agreement to ensure compliance with ethical and legal standards.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2026; primary completion for Dec 2026, 11 months later.

Of 276 non-industry observational studies under Renal Insufficiency, Chronic, half reached primary completion within 59 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 192. This study's planned 11 months is below that.

Counting every sponsor, half of 327 studies reached it within 45 months; a quarter within 22 and three quarters within 191.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 27, 2025
First posted
Oct 6, 2025
StartEst.
Jan 1, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2027
Last update
Oct 6, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07208994
Lead sponsor
Hospital del Mar
Collaborators
Organización Nacional de Trasplantes (ONT)
Responsible party
GUILLERMO PEDREIRA ROBLES (Principal Investigator, Hospital del Mar) — Principal investigator
First posted
Oct 6, 2025
Start date
Jan 1, 2026 (estimated)
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Oct 6, 2025

Study contacts

GUILLERMO PEDREIRA ROBLES, Dr
Contact
gpedreira@psmar.cat
+34 618491674
Montserrat Sanclemente Dalmau, Dr
principal investigator · Escola Superior d'Infermeria Hospital del Mar
Laura Rota Musoll, Dr
principal investigator · Universitat de Vic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion